| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4133304
[patent_doc_number] => 06147095
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => 'Method for improving the pharmacokinetics of tipranavir'
[patent_app_type] => 1
[patent_app_number] => 9/430742
[patent_app_country] => US
[patent_app_date] => 1999-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10593
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/147/06147095.pdf
[firstpage_image] =>[orig_patent_app_number] => 430742
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/430742 | Method for improving the pharmacokinetics of tipranavir | Oct 28, 1999 | Issued |
Array
(
[id] => 1533088
[patent_doc_number] => 06410535
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Prophylactic or therapeutic agents for diseases having vascular dysfunction associated with insulin resistance'
[patent_app_type] => B1
[patent_app_number] => 09/427579
[patent_app_country] => US
[patent_app_date] => 1999-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4232
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410535.pdf
[firstpage_image] =>[orig_patent_app_number] => 09427579
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/427579 | Prophylactic or therapeutic agents for diseases having vascular dysfunction associated with insulin resistance | Oct 26, 1999 | Issued |
Array
(
[id] => 4239670
[patent_doc_number] => 06080736
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam'
[patent_app_type] => 1
[patent_app_number] => 9/429503
[patent_app_country] => US
[patent_app_date] => 1999-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 11244
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080736.pdf
[firstpage_image] =>[orig_patent_app_number] => 429503
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/429503 | Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam | Oct 26, 1999 | Issued |
Array
(
[id] => 4401537
[patent_doc_number] => 06231894
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-15
[patent_title] => 'Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase'
[patent_app_type] => 1
[patent_app_number] => 9/421942
[patent_app_country] => US
[patent_app_date] => 1999-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 13
[patent_no_of_words] => 10786
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/231/06231894.pdf
[firstpage_image] =>[orig_patent_app_number] => 421942
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/421942 | Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase | Oct 20, 1999 | Issued |
| 90/005536 | COMPOSITION AND METHOD FOR TREATING ACUTE OR CHRONIC RHINOSINUSITIS | Oct 20, 1999 | Issued |
Array
(
[id] => 4143983
[patent_doc_number] => 06031006
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-29
[patent_title] => 'Method of treating diabetic nephropathy'
[patent_app_type] => 1
[patent_app_number] => 9/422486
[patent_app_country] => US
[patent_app_date] => 1999-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2282
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/031/06031006.pdf
[firstpage_image] =>[orig_patent_app_number] => 422486
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/422486 | Method of treating diabetic nephropathy | Oct 20, 1999 | Issued |
Array
(
[id] => 4248180
[patent_doc_number] => 06136807
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'Composition for the transdermal delivery of lerisetron'
[patent_app_type] => 1
[patent_app_number] => 9/419859
[patent_app_country] => US
[patent_app_date] => 1999-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4929
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136807.pdf
[firstpage_image] =>[orig_patent_app_number] => 419859
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/419859 | Composition for the transdermal delivery of lerisetron | Oct 18, 1999 | Issued |
Array
(
[id] => 4368491
[patent_doc_number] => 06274599
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Cisapride extended release'
[patent_app_type] => 1
[patent_app_number] => 9/419590
[patent_app_country] => US
[patent_app_date] => 1999-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2099
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274599.pdf
[firstpage_image] =>[orig_patent_app_number] => 419590
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/419590 | Cisapride extended release | Oct 17, 1999 | Issued |
Array
(
[id] => 4155958
[patent_doc_number] => 06103695
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Method of producing pleurodesis'
[patent_app_type] => 1
[patent_app_number] => 9/416869
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10409
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103695.pdf
[firstpage_image] =>[orig_patent_app_number] => 416869
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416869 | Method of producing pleurodesis | Oct 12, 1999 | Issued |
Array
(
[id] => 4383647
[patent_doc_number] => 06294579
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-25
[patent_title] => 'Method for improving delivery of tyrosine supplementation'
[patent_app_type] => 1
[patent_app_number] => 9/415808
[patent_app_country] => US
[patent_app_date] => 1999-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2109
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/294/06294579.pdf
[firstpage_image] =>[orig_patent_app_number] => 415808
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/415808 | Method for improving delivery of tyrosine supplementation | Oct 10, 1999 | Issued |
Array
(
[id] => 4208529
[patent_doc_number] => 06028095
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-22
[patent_title] => 'Treatment of inflammatory bowel disease using histamine H.sub.3 -receptor agonists'
[patent_app_type] => 1
[patent_app_number] => 9/416158
[patent_app_country] => US
[patent_app_date] => 1999-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2764
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/028/06028095.pdf
[firstpage_image] =>[orig_patent_app_number] => 416158
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416158 | Treatment of inflammatory bowel disease using histamine H.sub.3 -receptor agonists | Oct 10, 1999 | Issued |
Array
(
[id] => 4215148
[patent_doc_number] => 06039981
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Antifungal oral composition containing itraconazole and process for preparing same'
[patent_app_type] => 1
[patent_app_number] => 9/411510
[patent_app_country] => US
[patent_app_date] => 1999-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2588
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/039/06039981.pdf
[firstpage_image] =>[orig_patent_app_number] => 411510
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/411510 | Antifungal oral composition containing itraconazole and process for preparing same | Oct 3, 1999 | Issued |
Array
(
[id] => 4099625
[patent_doc_number] => 06048886
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin'
[patent_app_type] => 1
[patent_app_number] => 9/409278
[patent_app_country] => US
[patent_app_date] => 1999-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6641
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048886.pdf
[firstpage_image] =>[orig_patent_app_number] => 409278
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/409278 | Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin | Sep 29, 1999 | Issued |
Array
(
[id] => 4350600
[patent_doc_number] => 06214855
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Method for the treatment of stroke using N-heterocyclic glyoxlyamide compounds'
[patent_app_type] => 1
[patent_app_number] => 9/402084
[patent_app_country] => US
[patent_app_date] => 1999-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9102
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214855.pdf
[firstpage_image] =>[orig_patent_app_number] => 402084
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/402084 | Method for the treatment of stroke using N-heterocyclic glyoxlyamide compounds | Sep 28, 1999 | Issued |
Array
(
[id] => 4177533
[patent_doc_number] => 06149915
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Treatment of diabetic nephropathy and microalbuminuria'
[patent_app_type] => 1
[patent_app_number] => 9/408436
[patent_app_country] => US
[patent_app_date] => 1999-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 10373
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/149/06149915.pdf
[firstpage_image] =>[orig_patent_app_number] => 408436
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/408436 | Treatment of diabetic nephropathy and microalbuminuria | Sep 28, 1999 | Issued |
Array
(
[id] => 4295880
[patent_doc_number] => 06197788
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => '(-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders'
[patent_app_type] => 1
[patent_app_number] => 9/355205
[patent_app_country] => US
[patent_app_date] => 1999-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6497
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197788.pdf
[firstpage_image] =>[orig_patent_app_number] => 355205
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/355205 | (-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders | Sep 26, 1999 | Issued |
Array
(
[id] => 4235511
[patent_doc_number] => 06075028
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-13
[patent_title] => 'Method of treating Tourette\'s syndrome and related CNS disorders'
[patent_app_type] => 1
[patent_app_number] => 9/401302
[patent_app_country] => US
[patent_app_date] => 1999-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1191
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/075/06075028.pdf
[firstpage_image] =>[orig_patent_app_number] => 401302
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/401302 | Method of treating Tourette's syndrome and related CNS disorders | Sep 22, 1999 | Issued |
Array
(
[id] => 4382883
[patent_doc_number] => 06294533
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-25
[patent_title] => 'Calcium channel blockers'
[patent_app_type] => 1
[patent_app_number] => 9/401699
[patent_app_country] => US
[patent_app_date] => 1999-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6921
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/294/06294533.pdf
[firstpage_image] =>[orig_patent_app_number] => 401699
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/401699 | Calcium channel blockers | Sep 22, 1999 | Issued |
Array
(
[id] => 4119677
[patent_doc_number] => 06071974
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-06
[patent_title] => 'Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic drug and 2.5-di-O-methyl-1.4;3.6-dianhydro-D-glucitol as a solvent for making clear I. V. formulation'
[patent_app_type] => 1
[patent_app_number] => 9/401057
[patent_app_country] => US
[patent_app_date] => 1999-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3131
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/071/06071974.pdf
[firstpage_image] =>[orig_patent_app_number] => 401057
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/401057 | Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic drug and 2.5-di-O-methyl-1.4;3.6-dianhydro-D-glucitol as a solvent for making clear I. V. formulation | Sep 21, 1999 | Issued |
| 09/381461 | PREVENTIVES FOR RECONSTRICTION | Sep 20, 1999 | Abandoned |